Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mead

Showing results (411-420 of 435) with videos related to

Pageof 44
Sort By:
Blood|November 14, 2023
Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinibAlex Rampotas, Luke Carter-Brzezinski, Tim C P Somervaille, et al.
Blood|August 7, 2019
Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programsSorcha O'Byrne, Natalina Elliott, Siobhan Rice, et al.
Nature Immunology|May 30, 2024
Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cellsJoana Carrelha, Stefania Mazzi, Axel Winroth, et al.
Science Translational Medicine|July 1, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosisAlexandros Rampotas, Zoë C Wong, Isaac Gannon, et al.
Science Translational Medicine|September 13, 2021
Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemiaDeena Iskander, Guanlin Wang, Elisabeth F Heuston, et al.
Blood Advances|November 24, 2020
Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosisAaron T Gerds, Michael R Savona, Bart L Scott, et al.
Blood|December 9, 2022
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapyAnnatina S Schnegg-Kaufmann, Julie A I Thoms, Golam Sarower Bhuyan, et al.
Blood|April 14, 2022
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapiesClara Bueno, Susana Barrera, Alex Bataller, et al.
Nature Immunology|February 21, 2012
The earliest thymic T cell progenitors sustain B cell and myeloid lineage potentialSidinh Luc, Tiago C Luis, Hanane Boukarabila, et al.
Molecular Neurodegeneration|November 4, 2025
M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosisAmy F Keerie, Raquel Rua Martins, Chloe F Allen, et al.
Pageof 44

Showing results (411-420 of 435) with videos related to

Sort By:
Pageof 44
Blood|November 14, 2023
Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinibAlex Rampotas, Luke Carter-Brzezinski, Tim C P Somervaille, et al.
Blood|August 7, 2019
Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programsSorcha O'Byrne, Natalina Elliott, Siobhan Rice, et al.
Nature Immunology|May 30, 2024
Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cellsJoana Carrelha, Stefania Mazzi, Axel Winroth, et al.
Science Translational Medicine|July 1, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosisAlexandros Rampotas, Zoë C Wong, Isaac Gannon, et al.
Science Translational Medicine|September 13, 2021
Single-cell profiling of human bone marrow progenitors reveals mechanisms of failing erythropoiesis in Diamond-Blackfan anemiaDeena Iskander, Guanlin Wang, Elisabeth F Heuston, et al.
Blood Advances|November 24, 2020
Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosisAaron T Gerds, Michael R Savona, Bart L Scott, et al.
Blood|December 9, 2022
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapyAnnatina S Schnegg-Kaufmann, Julie A I Thoms, Golam Sarower Bhuyan, et al.
Blood|April 14, 2022
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapiesClara Bueno, Susana Barrera, Alex Bataller, et al.
Nature Immunology|February 21, 2012
The earliest thymic T cell progenitors sustain B cell and myeloid lineage potentialSidinh Luc, Tiago C Luis, Hanane Boukarabila, et al.
Molecular Neurodegeneration|November 4, 2025
M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosisAmy F Keerie, Raquel Rua Martins, Chloe F Allen, et al.
Pageof 44